ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
COVID-19 S-Trimer vaccine candidates show promise in early trials
December 08, 2020When adjuvanted with GSK’s pandemic adjuvant system, the S-Trimer vaccine candidates induced the production of neutralising antibodies in all trial participants. -
CEPI extends partnership with Clover Biopharma to fund COVID-19 vaccine candidate
November 04, 2020CEPI to fund the development of Clover’s protein-based S-Trimer vaccine candidate through to licensure, including a global pivotal Phase 2/3 efficacy clinical study beginning before the end of 2020. -
CEPI Expands Partnership with Clover
July 14, 2020To rapidly advance development and manufacture of COVID-19 vax candidate, invests an additional $66M upfront in Clover’s S-Trimer protein.
Pharma Sources Insight January 2025
